ADIPOQ and colorectal carcinoma: Administration of MK-7 showed preventive effects by suppressing CRC-risk microorganisms and metabolites (short-chain fatty acids, SCFAs), promoting serum adiponectin level, stimulating the VDR expression to trigger different anti-inflammatory and anti-tumorigenic pathways (15).